Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes - PubMed (original) (raw)

Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes

M A Morsy et al. J Clin Invest. 1993 Sep.

Abstract

100% of primary human hepatocytes infected with an adenoviral vector carrying beta-galactosidase expressed the exogenous gene. Expression was also achieved in > 40% of adult mouse hepatocytes in vivo. Normal levels of activity were achieved in mouse ornithine transcarbamylase (OTC)-deficient primary hepatocytes using another adenoviral vector carrying human OTC cDNA. Study of OTC-deficient primary human hepatocytes from a single patient confirmed the utility of adenoviral delivery of OTC. We describe adenoviral-mediated exogenous gene expression in human and mouse hepatocytes in vitro and in mouse liver in vivo. Data suggest that adenoviral vectors may be useful for correcting OTC deficiency.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pediatr Res. 1979 Jul;13(7):807-11 - PubMed
    1. J Gen Virol. 1977 Jul;36(1):59-74 - PubMed
    1. Gene. 1982 Jul-Aug;19(1):33-42 - PubMed
    1. Cell. 1983 Jul;33(3):683-93 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Mar;81(5):1411-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources